CN108727408B - A kind of pyrido-oxifurazan energetic compound and preparation method thereof - Google Patents

A kind of pyrido-oxifurazan energetic compound and preparation method thereof Download PDF

Info

Publication number
CN108727408B
CN108727408B CN201710251607.0A CN201710251607A CN108727408B CN 108727408 B CN108727408 B CN 108727408B CN 201710251607 A CN201710251607 A CN 201710251607A CN 108727408 B CN108727408 B CN 108727408B
Authority
CN
China
Prior art keywords
reaction
amino
compound
dinitropyridine
dichloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201710251607.0A
Other languages
Chinese (zh)
Other versions
CN108727408A (en
Inventor
马丛明
刘祖亮
姚其正
周九九
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Science and Technology
Original Assignee
Nanjing University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Science and Technology filed Critical Nanjing University of Science and Technology
Priority to CN201710251607.0A priority Critical patent/CN108727408B/en
Publication of CN108727408A publication Critical patent/CN108727408A/en
Application granted granted Critical
Publication of CN108727408B publication Critical patent/CN108727408B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

本发明公开了一种吡啶并氧化呋咱含能化合物及其制备方法。该方法是在一定温度下实现对4‑氨基‑2,6‑二氯‑3,5‑二硝基吡啶的叠氮化及脱氮闭环反应,反应结束后将混合物减压旋蒸,加水溶解,经萃取后有机相用无水硫酸钠干燥,过滤,滤液减压旋蒸即可。本发明合成的含能化合物结构新颖,反应条件温和,不需要特别装置、工艺和操作过程简单、生产安全可靠、产物后处理便捷、环境污染小,满足工业放大生产的基本要求;该化合物兼具四唑、氧化呋咱和氨基硝基吡啶的结构,在含能材料领域有潜在的应用,理论计算爆速达到8754 m/s。

Figure 201710251607

The invention discloses a pyridofurazan energetic compound and a preparation method thereof. The method is to realize the azide and denitrification ring-closure reaction of 4-amino-2,6-dichloro-3,5-dinitropyridine at a certain temperature, and after the reaction is completed, the mixture is decompressed and rotary-evaporated, and dissolved in water. After extraction, the organic phase was dried with anhydrous sodium sulfate, filtered, and the filtrate was evaporated under reduced pressure. The energy-containing compound synthesized by the invention has novel structure, mild reaction conditions, no need for special devices, simple process and operation process, safe and reliable production, convenient product post-processing, low environmental pollution, and meets the basic requirements of industrial scale-up production; the compound has both The structures of tetrazole, furoxan and aminonitropyridine have potential applications in the field of energetic materials, and the theoretical detonation velocity reaches 8754 m/s.

Figure 201710251607

Description

Pyridofuroxan energetic compound and preparation method thereof
Technical Field
The invention belongs to the technical field of explosive synthesis processes, and particularly relates to a synthesis method of an energetic compound 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide.
Background
In the field of energetic materials, an energetic derivative taking a furazan oxide group as an explosive group has the following characteristics: 1) furazan oxide groups can provide relatively higher energy densities; 2) the effective oxygen content is high, and the furoxan derivative as an energetic additive can improve the oxygen balance of a system; 3) the furoxan group can endow the derivative with ring tension and high standard formation enthalpy. If one nitro group is replaced by one furazan oxide group, the density can be improved by 0.06-0.08 g/cm3The detonation velocity can be improved by 300 m/s. Furthermore, the introduction of heterocyclic systems may greatly favor combinations of their atomic orbitals over carbocyclic systems due to intramolecular perturbations, since heteroatoms play an important role in the lowest molecular orbital level. But additionallyThe stabilization effect brought by the charge density can often improve the heat resistance of the explosive and reduce the mechanical sensitivity of the explosive. The introduction of ortho amino and nitro groups on the pyridine ring to form intramolecular and intermolecular hydrogen bonds can improve the safety performance and crystal density of energetic compounds; the introduction of nitrogen-rich compounds increases the energy of the energy-containing compounds. However, researchers at home and abroad have only reported on compounds having tetrazole, furazan oxide and amino nitropyridine structures.
J Energ Mater,2005,23(2):99-106 reported that a synthetic route of an energetic compound having tetrazole, furazan oxide groups is shown as follows. The route takes 2, 6-dimethoxy pyridine as a raw material, and 7-nitrotetrazolyl [1,5-f ] furazano [4,5-b ] pyridine-1-oxide (NFP) is synthesized by nitration, hydrazine substitution, azidation and pyrolysis denitrification, and the decomposition point is about 160 ℃. The method has long synthetic route and low utilization rate of substituent groups of pyridine rings.
Figure BDA0001272240270000021
Chin J Chem,2013,31:1299-1304 reports a synthetic route of an energy-containing compound with a furazan oxide ring and an amino nitropyridine structure as shown in the following formula. The method takes 2-chloro-4-aminopyridine as a raw material, takes ethanol/water as a solvent, completes an azidation reaction at room temperature, and performs pyrolysis denitrification and ring closure under an acidic condition to obtain the 7-amino-6-nitro- [1,2,5] oxadiazol [3,4-b ] pyridine-1-oxide. The theoretical calculation detonation velocity of the compound is only 7.51km/s, and the detonation performance of the pyridine ring series energetic compound cannot be fully exerted.
Figure BDA0001272240270000022
Disclosure of Invention
The invention aims to provide a pyridofuroxan energetic compound 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide and a preparation method thereof.
In order to solve the technical problems, the invention adopts a technical scheme that:
a pyridofuroxan energetic compound (named 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide) has the following structure:
Figure BDA0001272240270000031
the preparation method of the compound comprises the following steps:
dissolving 4-amino-2, 6-dichloro-3, 5-dinitropyridine in an organic solvent, adding sodium azide at room temperature, and stirring for reaction for more than 30 min;
and secondly, adding a small amount of concentrated hydrochloric acid into the reaction mixed solution, heating to react for a period of time, evaporating the solvent from the mixed solution under reduced pressure after the reaction is finished, adding water to dissolve the solvent, extracting with ethyl acetate, drying the organic phase, and distilling under reduced pressure to obtain the target compound.
Wherein, in the first step, the mol ratio of the 4-amino-2, 6-dichloro-3, 5-dinitropyridine to the sodium azide is 1:2-1: 4.
In the first step, the organic solvent comprises acetonitrile, ethyl acetate, tetrahydrofuran, acetone, methanol, ethanol and a mixture thereof, preferably any one or a combination of acetonitrile, tetrahydrofuran and acetone.
In the second step, the mass of the concentrated hydrochloric acid is 1/20-1/30 of 4-amino-2, 6-dichloro-3, 5-dinitropyridine, the reaction temperature of the mixed solution is 30-50 ℃, and the reaction time is 1-3 hours.
Compared with the prior art, the invention has the following remarkable advantages: the invention synthesizes the fully-substituted pyridofuroxan energetic compound for the first time: the 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide has the advantages of simple synthesis reaction steps, mild conditions, no need of special devices, safe and reliable production, simple product post-treatment, small environmental hazard and capability of meeting the basic requirements of industrial amplification production; the compound has the structure of tetrazole, furazan oxide and amino nitropyridine, the detonation velocity is 8754m/s theoretically calculated, and the compound can be possibly used in the field of high-energy insensitive energetic materials.
The present invention is described in further detail below with reference to the attached drawing figures.
Drawings
FIG. 1 of pyridofuroxan energetic compounds of the invention1H NMR spectrum.
Detailed Description
The following detailed description of the preferred embodiments of the present invention is provided to enable those skilled in the art to more readily understand the advantages and features of the present invention, and to clearly and unequivocally define the scope of the present invention.
The 4-amino-5-nitro- [1,2,5] of the invention]Oxadiazole [3,4-e ] s]Tetrazole [1,5-a ]]Pyridine-3-oxides having the formula C5H2N8O4The structural formula is as follows:
Figure BDA0001272240270000041
the synthetic route of the 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide is as follows:
Figure BDA0001272240270000042
the invention relates to a preparation method of 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide, which comprises the following steps:
dissolving 4-amino-2, 6-dichloro-3, 5-dinitropyridine in a proper solvent, adding sodium azide at room temperature, and stirring for reaction for 1 h;
and secondly, adding a small amount of concentrated hydrochloric acid into the reaction mixed solution, heating to react for a period of time, evaporating the solvent from the mixed solution under reduced pressure after the reaction is finished, adding water to dissolve the solvent, extracting the mixture by ethyl acetate, drying an organic phase, and distilling under reduced pressure to obtain the 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide.
Wherein, in the first step, the mol ratio of the 4-amino-2, 6-dichloro-3, 5-dinitropyridine to the sodium azide is 1:2-1:4, and the solvent for dissolving the 4-amino-2, 6-dichloro-3, 5-dinitropyridine comprises acetonitrile, ethyl acetate, tetrahydrofuran, acetone, methanol, ethanol and a mixture thereof. Wherein, the reaction solvent preferably comprises acetonitrile, tetrahydrofuran and acetone.
In the second step, the mass of the concentrated hydrochloric acid is 1/20-1/30 of 4-amino-2, 6-dichloro-3, 5-dinitropyridine, the reaction temperature of the mixed solution is 30-50 ℃, and the reaction time is 1-3 hours.
Example 1
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine was dissolved in 15mL of acetonitrile, and 0.65g (10mmol) of sodium azide was added thereto at room temperature under stirring, followed by reaction with stirring for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 30 ℃ for reaction for 3 hours. After the reaction is finished, the mixed solution is decompressed and steamed, dissolved by adding water, extracted by ethyl acetate, dried and filtered by the organic phase, and the filtrate is decompressed and distilled to obtain yellow solid 4-amino-5-nitro- [1,2, 5-nitro- [1]Oxadiazole [3,4-e ] s]Tetrazole [1,5-a ]]Pyridine-3-oxide 0.89g, yield 75%. m.p.150-151 ℃ (dec.);1H NMR(DMSO-d6,400MHz):δ10.17(s,1H),9.50(s,1H);13C NMR(DMSO-d6100MHz) delta 148.96,144.27,141.87,111.17,105.06; MS (ESI) M/z:239.0(M + H), see FIG. 1.
The compound has the structures of tetrazole, furazan oxide and amino nitropyridine, the detonation velocity is calculated up to 8754m/s theoretically, and the compound has potential application in the field of high-energy insensitive energetic materials.
Example 2
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine is dissolved in 15mL of a mixed solvent of ethyl acetate and acetone, 0.98g (15mmol) of sodium azide is added under stirring at room temperature, and the mixture is stirred and reacted for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 35 ℃ for reaction for 2.5 h. After the reaction, the mixture was rotary-distilled under reduced pressure, dissolved in water, extracted with ethyl acetate, the organic phase was dried, filtered, and the filtrate was distilled under reduced pressure to give 0.71g of 4-amino-5-nitro- [1,2,5] oxadiazol [3,4-e ] tetrazolo [1,5-a ] pyridine-3-oxide as a yellow solid in 60% yield.
Example 3
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine is dissolved in 15mL of ethanol, 0.98g (15mmol) of sodium azide is added under stirring at room temperature, and the mixture is stirred and reacted for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 50 ℃ for reaction for 1.5 h. After the reaction, the mixture was rotary-distilled under reduced pressure, dissolved in water, extracted with ethyl acetate, the organic phase was dried, filtered, and the filtrate was distilled under reduced pressure to give 0.62g of 4-amino-5-nitro- [1,2,5] oxadiazol [3,4-e ] tetrazolo [1,5-a ] pyridine-3-oxide as a yellow solid in 52% yield.
Example 4
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine was dissolved in 15mL of acetone, and 1.30g (20mmol) of sodium azide was added thereto at room temperature with stirring, followed by reaction with stirring for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 30 ℃ for reaction for 2 hours. After the reaction, the mixture was rotary-distilled under reduced pressure, dissolved in water, extracted with ethyl acetate, the organic phase was dried, filtered, and the filtrate was distilled under reduced pressure to give 0.80g of 4-amino-5-nitro- [1,2,5] oxadiazol [3,4-e ] tetrazolo [1,5-a ] pyridine-3-oxide as a yellow solid in 67% yield.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes performed by the present specification and drawings, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.

Claims (7)

1.一种吡啶并氧化呋咱含能化合物,其特征在于,其结构如下:1. a pyrido oxyfurazan energetic compound, is characterized in that, its structure is as follows:
Figure FDA0001272240260000011
Figure FDA0001272240260000011
2.如权利要求1所述的化合物的制备方法,其特征在于,包括以下步骤:2. the preparation method of compound as claimed in claim 1, is characterized in that, comprises the following steps: 第一步,将4-氨基-2,6-二氯-3,5-二硝基吡啶溶于有机溶剂中,在室温下加入叠氮化钠,搅拌反应30min以上;In the first step, 4-amino-2,6-dichloro-3,5-dinitropyridine is dissolved in an organic solvent, sodium azide is added at room temperature, and the reaction is stirred for more than 30min; 第二步,向反应混合液中加入少量浓盐酸,升温反应一段时间,待反应完成后,混合液经减压旋蒸掉溶剂,加水溶解,乙酸乙酯萃取,有机相干燥、减压蒸馏得到目标化合物。In the second step, a small amount of concentrated hydrochloric acid was added to the reaction mixture, and the temperature was raised to react for a period of time. After the reaction was completed, the mixture was evaporated under reduced pressure to remove the solvent, dissolved in water, extracted with ethyl acetate, and the organic phase was dried and distilled under reduced pressure to obtain target compound. 3.如权利要求2所述的方法,其特征在于,第一步中,4-氨基-2,6-二氯-3,5-二硝基吡啶和叠氮化钠的摩尔比为1:2~1:4。3. method as claimed in claim 2 is characterized in that, in the first step, the mol ratio of 4-amino-2,6-dichloro-3,5-dinitropyridine and sodium azide is 1: 2 to 1:4. 4.如权利要求2所述的方法,其特征在于,第一步中,有机溶剂包括乙腈、乙酸乙酯、四氢呋喃、丙酮、甲醇、乙醇及其混合物。4. The method of claim 2, wherein in the first step, the organic solvent comprises acetonitrile, ethyl acetate, tetrahydrofuran, acetone, methanol, ethanol and mixtures thereof. 5.如权利要求2所述的方法,其特征在于,第一步中,有机溶剂包括乙腈、四氢呋喃和丙酮中任意一种或其组合。5. The method of claim 2, wherein in the first step, the organic solvent comprises any one or a combination of acetonitrile, tetrahydrofuran and acetone. 6.如权利要求2所述的方法,其特征在于,第二步中,浓盐酸的质量为4-氨基-2,6-二氯-3,5-二硝基吡啶质量的1/20~1/30。6. method as claimed in claim 2 is characterized in that, in the second step, the quality of concentrated hydrochloric acid is 1/20~20 of the quality of 4-amino-2,6-dichloro-3,5-dinitropyridine 1/30. 7.如权利要求2所述的方法,其特征在于,第二步中,混合液的反应温度为30~50℃,反应时间为1~3h。7 . The method of claim 2 , wherein in the second step, the reaction temperature of the mixed solution is 30-50° C., and the reaction time is 1-3 h. 8 .
CN201710251607.0A 2017-04-18 2017-04-18 A kind of pyrido-oxifurazan energetic compound and preparation method thereof Expired - Fee Related CN108727408B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710251607.0A CN108727408B (en) 2017-04-18 2017-04-18 A kind of pyrido-oxifurazan energetic compound and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710251607.0A CN108727408B (en) 2017-04-18 2017-04-18 A kind of pyrido-oxifurazan energetic compound and preparation method thereof

Publications (2)

Publication Number Publication Date
CN108727408A CN108727408A (en) 2018-11-02
CN108727408B true CN108727408B (en) 2021-04-16

Family

ID=63924204

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710251607.0A Expired - Fee Related CN108727408B (en) 2017-04-18 2017-04-18 A kind of pyrido-oxifurazan energetic compound and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108727408B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113321666B (en) * 2020-02-28 2022-05-20 南京理工大学 Energetic compounds based on cyclic skeletons and methods for their synthesis
CN112521402A (en) * 2020-12-15 2021-03-19 北京理工大学 1,2, 4-oxadiazole [5,5] bicyclic fused ring compound and preparation method thereof
CN115746021B (en) * 2022-11-23 2024-02-13 中国工程物理研究院化工材料研究所 Synthesis method of 7-amino-6-nitrobenzofuroxan and isomer thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450108A (en) * 2012-06-04 2013-12-18 南京理工大学 Polyaminopolynitrobenzofuroxan metal complex and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450108A (en) * 2012-06-04 2013-12-18 南京理工大学 Polyaminopolynitrobenzofuroxan metal complex and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
7-氨基-6-硝基-[1,2,5]噁二唑并[3,4-b]吡啶-1-氧化物合成及性能;马丛明,等;《含能材料》;20141231;第22卷(第14期);第573页化合物3,合成路线、实验内容 *
Preparation, characterization, and properties of 7-nitrotetrazolo[1,5-f]furazano[4,5-b]pyridine 1-oxide;My Hang V. Huynh,等;《Journal of Energetic Materials》;20060902;第23卷(第2期);第100页化合物NFP,102页NFP合成路线 *

Also Published As

Publication number Publication date
CN108727408A (en) 2018-11-02

Similar Documents

Publication Publication Date Title
CN103524444A (en) Synthetic method of 5, 5'-bistetrazole-1, 1'-dioxo hydroxyl ammonium salt (TKX-50)
CN112661749B (en) Energetic salt containing oxadiazole ring geminal dinitro group and preparation method thereof
CN108727408B (en) A kind of pyrido-oxifurazan energetic compound and preparation method thereof
CN103694181B (en) Synthetic method of 2, 6-diamino-3, 5-binitropyrazine-1-oxide
CN114634462B (en) Furazan-containing cyclonitrate simulated energetic compound or usable salt thereof and preparation method thereof
CN102250007A (en) Preparation method of 3,4-binitropyrazole
CN114957125B (en) Synthesis method of 4-nitro-5-nitroaminopyrazole
CN113321666B (en) Energetic compounds based on cyclic skeletons and methods for their synthesis
CN104151195B (en) A kind of one-pot synthesis method of diazido glyoxime
CN112194625A (en) 1, 4-dinitroamino-3, 5-dinitropyrazole oxalyl dihydrazide nitrate, preparation method and application thereof
CN109970676A (en) Trinitrethylaminobifurazan and its synthesis method
CN105272929A (en) 5-nitryl-1,2,4-triazole-5-ketone compound of oxalyl dihydrazide
Xue et al. Methyl nitrate energetic compounds based on bicyclic scaffolds of furazan–isofurazan (isoxazole): syntheses, crystal structures and detonation performances
CN104496916A (en) Preparation method of 1-oxy-2, 6-diamido-3, 5-dinitropyrazine
CN114315739A (en) High-energy low-sensitivity energetic compound and preparation method thereof
CN115521265A (en) High nitrogen compound and synthesis method thereof
CN105566244A (en) Synthetic method for 3-(4-aminofurazan-3-radical)-4-(4-nitrofurazan-3-radical) furazan
CN103193560A (en) Nitramine explosive and preparation method thereof
CN114644600B (en) High-heat-stability high explosive and preparation method thereof
CN108586379B (en) A kind of preparation method of 3-aminofurazan-4-carboxamide
CN105440037A (en) Preparation method for 1,4,5,8-tetranitro-1,4,5,8-tetraazabicyclo[4.4.0]decane
CN107266376B (en) LLM-105 nitramine derivatives and preparation method thereof
CN119462528A (en) 6,8-Dinitroquinazoline-2,4(1H,3H)-dione energetic compound and its synthesis method
CN104059022B (en) One prepares the method for 2,4,5-trinitro-imidazoles
CN103804385B (en) The method of 1,3,4-tri-substituted azole derivatives

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210416